| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.048 | 0.8 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |